Comparative transdermal permeation of drugs
Research type
Research Study
Full title
Comparative transdermal permeation of active compounds from a range of platform dosage forms using horizontal diffusion cell technology with human skin
IRAS ID
258224
Contact name
Steve Metcalf
Contact email
Sponsor organisation
Nemaura Pharma Ltd
Clinicaltrials.gov Identifier
Not applicable, Not applicable
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Nemaura Pharma propose to procure human skin samples from a suitably accredited tissue bank such as Tissue Solutions, Glasgow and use them in the comparative in-vitro assessment of permeation from different formulation platforms, using horizontal diffusion (Franz) cell technology.
REC name
London - Chelsea Research Ethics Committee
REC reference
18/LO/2236
Date of REC Opinion
3 Jan 2019
REC opinion
Favourable Opinion